Click on the protein name for more information about the protein.
The Score column is the predicted score of interaction between the two proteins
Click on the Evidence link to view a breakdown of the information about the predicted interaction.
Key | |
---|---|
Module Score | Databases |
![]() | Where interaction is observed in another database a link is provided: |
Protein 1 (?) | Protein 2 (?) | Name of Protein 2 | Module Scores (?) | Scores (?) | Evidence (?) | Database (?) | |||
---|---|---|---|---|---|---|---|---|---|
![]() | ![]() | ![]() | ![]() | ||||||
LYN | FGR | FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR | 1.78E3 | Evidence | |||||
LYN | SYK | SYK: Tyrosine-protein kinase SYK | 1.71E3 | Evidence |
![]() ![]() |
||||
LYN | VAV1 | VAV1, VAV: Proto-oncogene vav | 1.53E3 | Evidence | |||||
LYN | SH3BP2 | SH3BP2: Uncharacterized protein SH3BP2 | 1.30E3 | Evidence | |||||
LYN | JAK2 | JAK2: Tyrosine-protein kinase JAK2 | 934.0 | Evidence |
![]() |
||||
LYN | HCK | N/A | 720.0 | Evidence | |||||
LYN | BTK | BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK | 613.0 | Evidence |
![]() |
||||
LYN | TYK2 | TYK2: Non-receptor tyrosine-protein kinase TYK2 | 613.0 | Evidence |
![]() |
||||
LYN | JAK1 | 486.0 | Evidence | ||||||
LYN | STAT5A | STAT5A, STAT5: Signal transducer and activator of transcription 5A | 407.0 | Evidence | |||||
LYN | BLNK | BLNK, BASH, SLP65: B-cell linker protein | 392.0 | Evidence | |||||
LYN | CSF1R | CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor | 379.0 | Evidence |
![]() |
||||
LYN | STAT5B | STAT5B: Signal transducer and activator of transcription 5B | 373.0 | Evidence | |||||
LYN | SLA | SLA, SLAP, SLAP1: SRC-like-adapter | 370.0 | Evidence | |||||
LYN | NCK1 | NCK1, NCK: Cytoplasmic protein NCK1 | 268.0 | Evidence | |||||
LYN | FYN | FYN: Proto-oncogene tyrosine-protein kinase Fyn | 268.0 | Evidence | |||||
LYN | NCK2 | NCK2: Cytoplasmic protein NCK2 | 259.0 | Evidence | |||||
LYN | CRKL | CRKL: Crk-like protein | 247.0 | Evidence |
![]() |
||||
LYN | LCP2 | LCP2: Lymphocyte cytosolic protein 2 | 224.0 | Evidence |
![]() ![]() |
||||
LYN | ZAP70 | ZAP70: Uncharacterized protein ZAP70 | 209.0 | Evidence | |||||
LYN | WAS | WAS, IMD2: Wiskott-Aldrich syndrome protein | 194.0 | Evidence | |||||
LYN | SRC | SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src | 181.0 | Evidence | |||||
LYN | APS | SH2B2, APS: SH2B adapter protein 2 | 180.0 | Evidence |
![]() |
||||
LYN | TEC | TEC, PSCTK4: Tyrosine-protein kinase Tec | 167.0 | Evidence |
![]() |
||||
LYN | HCLS1 | HCLS1, HS1: Hematopoietic lineage cell-specific protein | 165.0 | Evidence |
![]() |
||||
LYN | PTPN6 | PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 | 156.0 | Evidence |
![]() |
||||
LYN | RPS6KA1 | RPS6KA1, RSK1: Ribosomal protein S6 kinase alpha-1 | 148.0 | Evidence | |||||
LYN | LCK | LCK: Proto-oncogene tyrosine-protein kinase LCK | 143.0 | Evidence | |||||
LYN | GRB2 | GRB2, ASH: Growth factor receptor-bound protein 2 | 139.0 | Evidence | |||||
LYN | STAT2 | STAT2: Signal transducer and activator of transcription 2 | 135.0 | Evidence | |||||
LYN | PDGFRB | PDGFRB: Beta-type platelet-derived growth factor receptor precursor | 134.0 | Evidence | |||||
LYN | INSR | INSR: Insulin receptor precursor | 132.0 | Evidence | |||||
LYN | STAT1 | STAT1: Signal transducer and activator of transcription 1-alpha/beta | 121.0 | Evidence | |||||
LYN | CBLB | CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B | 121.0 | Evidence | |||||
LYN | RASA1 | RASA1, RASA: Ras GTPase-activating protein 1 | 119.0 | Evidence |
![]() |
||||
LYN | ITK | ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK | 119.0 | Evidence | |||||
LYN | GRAP2 | GRAP2, GADS, GRB2L, GRID: GRB2-related adapter protein 2 | 109.0 | Evidence | |||||
LYN | TXK | TXK, PTK4: Tyrosine-protein kinase TXK | 109.0 | Evidence | |||||
LYN | SOCS3 | SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 | 109.0 | Evidence | |||||
LYN | PIK3R2 | PIK3R2: Phosphatidylinositol 3-kinase regulatory subunit beta | 108.0 | Evidence | |||||
LYN | STAT3 | 106.0 | Evidence | ||||||
LYN | PTK2B | PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta | 106.0 | Evidence |
![]() |
||||
LYN | ITGB2 | ITGB2, CD18, MFI7: Integrin beta-2 precursor | 97.70 | Evidence | |||||
LYN | EGFR | EGFR, ERBB1: Epidermal growth factor receptor precursor | 89.20 | Evidence |
![]() |
||||
LYN | ABL1 | ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 | 88.80 | Evidence | |||||
LYN | PDGFRA | PDGFRA: Alpha-type platelet-derived growth factor receptor precursor | 81.20 | Evidence | |||||
LYN | KIT | KIT: Mast/stem cell growth factor receptor precursor | 80.00 | Evidence |
![]() ![]() |
||||
LYN | KDR | KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor | 80.00 | Evidence | |||||
LYN | CBL | CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL | 78.20 | Evidence |
![]() ![]() ![]() |
||||
LYN | BMX | N/A | 70.50 | Evidence | |||||
LYN | INSL3 | JAK3: Tyrosine-protein kinase JAK3 | 70.50 | Evidence | |||||
LYN | DUSP1 | DUSP1, CL100, MKP1, PTPN10, VH1: Dual specificity protein phosphatase 1 | 67.00 | Evidence | |||||
LYN | YES1 | YES1, YES: Proto-oncogene tyrosine-protein kinase Yes | 63.20 | Evidence | |||||
LYN | ERBB2 | ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor | 58.60 | Evidence | |||||
LYN | GRB10 | N/A | 56.20 | Evidence | |||||
LYN | RAF1 | RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase | 55.10 | Evidence | |||||
LYN | FLT1 | FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor | 53.30 | Evidence | |||||
LYN | MST1R | MST1R, PTK8, RON: Macrophage-stimulating protein receptor precursor | 53.30 | Evidence | |||||
LYN | IGF1R | IGF1R: Insulin-like growth factor 1 receptor precursor | 52.50 | Evidence | |||||
LYN | IL10RA | IL10RA, IL10R: Interleukin-10 receptor alpha chain precursor | 51.10 | Evidence | |||||
LYN | IFNGR1 | IFNGR1: Interferon-gamma receptor alpha chain precursor | 51.10 | Evidence | |||||
LYN | KHDRBS1 | KHDRBS1, SAM68: KH domain-containing, RNA-binding, signal transduction-associate | 47.80 | Evidence |
![]() |
||||
LYN | EPHB3 | EPHB3, ETK2, HEK2, TYRO6: Ephrin type-B receptor 3 precursor | 47.30 | Evidence | |||||
LYN | NCF4 | NCF4, SH3PXD4: Neutrophil cytosol factor 4 | 46.90 | Evidence | |||||
LYN | DOK1 | DOK1: Docking protein 1 | 46.90 | Evidence |
![]() |
||||
LYN | IRAK1 | IRAK1, IRAK: Interleukin-1 receptor-associated kinase 1 | 46.90 | Evidence | |||||
LYN | ADRBK1 | ADRBK1, BARK, BARK1, GRK2: Beta-adrenergic receptor kinase 1 | 44.40 | Evidence | |||||
LYN | WASPIP | N/A | 42.00 | Evidence | |||||
LYN | EHD1 | EHD1, PAST, CDABP0131, PAST1: EH domain-containing protein 1 | 42.00 | Evidence | |||||
LYN | MAP4K1 | MAP4K1, HPK1: Mitogen-activated protein kinase kinase kinase kinase 1 | 37.80 | Evidence |
![]() |
||||
LYN | ROCK1 | ROCK1: Rho-associated protein kinase 1 | 37.80 | Evidence | |||||
LYN | PTPN12 | PTPN12: Tyrosine-protein phosphatase non-receptor type 12 | 33.90 | Evidence | |||||
LYN | MAP2K2 | MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki | 32.80 | Evidence | |||||
LYN | CSF2RB | CSF2RB, IL3RB, IL5RB: Cytokine receptor common beta chain precursor | 30.90 | Evidence |
![]() |
||||
LYN | IRS2 | IRS2: Insulin receptor substrate 2 | 27.90 | Evidence | |||||
LYN | S100A11 | MLN70, S100A11, S100C: Protein S100-A11 | 27.90 | Evidence | |||||
LYN | OSTF1 | N/A | 26.70 | Evidence | |||||
LYN | GRAP | GRAP: GRB2-related adapter protein | 26.00 | Evidence | |||||
LYN | ELMO2 | ELMO2, CED12A, KIAA1834: Engulfment and cell motility protein 2 | 25.00 | Evidence | |||||
LYN | SH3BP5 | N/A | 25.00 | Evidence | |||||
LYN | CXCR4 | CXCR4: C-X-C chemokine receptor type 4 | 24.90 | Evidence | |||||
LYN | PECAM1 | PECAM1: Platelet endothelial cell adhesion molecule precursor | 24.10 | Evidence |
![]() |
||||
LYN | CISH | CISH, G18: Cytokine-inducible SH2-containing protein | 24.10 | Evidence | |||||
LYN | HLA-E | HLA-E, XXbac-BPG34K20.2-001: MHC class Ib antigen | 21.00 | Evidence | |||||
LYN | HLA-DRB5 | HLA-Dw12: Cell surface glycoprotein | 21.00 | Evidence | |||||
LYN | FCER1G | FCER1G: High affinity immunoglobulin epsilon receptor subunit gamma precursor | 21.00 | Evidence |
![]() |
||||
LYN | STAM2 | STAM2: Signal transducing adapter molecule 2 | 20.40 | Evidence | |||||
LYN | CD79A | CD79A, IGA, MB1: B-cell antigen receptor complex-associated protein alpha-chain | 18.40 | Evidence |
![]() |
||||
LYN | PTPN1 | PTP1B, PTPN1: Tyrosine-protein phosphatase non-receptor type 1 | 18.40 | Evidence | |||||
LYN | SOCS1 | SOCS1, SSI1, TIP3: Suppressor of cytokine signaling 1 | 17.90 | Evidence | |||||
LYN | DUSP6 | DUSP6, MKP3, PYST1: Dual specificity protein phosphatase 6 | 17.60 | Evidence | |||||
LYN | ARHGEF7 | N/A | 17.60 | Evidence | |||||
LYN | RPS6KA2 | RPS6KA2, RSK3: Ribosomal protein S6 kinase alpha-2 | 17.60 | Evidence | |||||
LYN | MKNK1 | MKNK1, MNK1: MAP kinase-interacting serine/threonine-protein kinase 1 | 17.60 | Evidence | |||||
LYN | CIB1 | CIB1, CIB, KIP, PRKDCIP: Calcium and integrin-binding protein 1 | 17.30 | Evidence | |||||
LYN | TUBA1 | TUBA4A, TUBA1: Tubulin alpha-4A chain | 16.50 | Evidence | |||||
LYN | SOCS5 | SOCS5, CIS6, CISH5, CISH6, KIAA0671: Suppressor of cytokine signaling 5 | 15.80 | Evidence | |||||
LYN | SOCS2 | SOCS2, CIS2, SSI2, STATI2: Suppressor of cytokine signaling 2 | 15.80 | Evidence | |||||
LYN | PLD2 | PLD2: Phospholipase D2 | 15.30 | Evidence | |||||
LYN | CCR5 | CCR5: CCR5 receptor (Fragment) | 15.00 | Evidence | |||||
LYN | CD22 | CD22, SIGLEC2: B-cell receptor CD22 precursor | 15.00 | Evidence |
![]() |
||||
LYN | IL2RB | IL2RB: Interleukin-2 receptor subunit beta precursor | 15.00 | Evidence |
![]() |
||||
LYN | SNCA | SNCA, NACP, PARK1: Alpha-synuclein | 15.00 | Evidence |
![]() |
||||
LYN | MAPK10 | MAPK10, JNK3, JNK3A, PRKM10: Mitogen-activated protein kinase 10 | 15.00 | Evidence | |||||
LYN | CNN2 | CNN2: Calponin-2 | 15.00 | Evidence | |||||
LYN | AP1GBP1 | AP1GBP1, SYNG: AP1 subunit gamma-binding protein 1 | 13.40 | Evidence | |||||
LYN | BIN1 | BIN1, AMPHL: Myc box-dependent-interacting protein 1 | 13.40 | Evidence | |||||
LYN | SNX3 | N/A | 13.40 | Evidence | |||||
LYN | DAPP1 | N/A | 13.10 | Evidence |
![]() |
||||
LYN | NCF2 | NCF2: Neutrophil cytosol factor 2 | 12.50 | Evidence | |||||
LYN | MAPK3 | MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 | 12.40 | Evidence |
![]() |
||||
LYN | YWHAB | YWHAB: 14-3-3 protein beta/alpha | 11.70 | Evidence | |||||
LYN | IFNAR1 | IFNAR1, IFNAR: Interferon-alpha/beta receptor alpha chain precursor | 11.40 | Evidence | |||||
LYN | H1FX | H1FX: Histone H1x | 11.30 | Evidence | |||||
LYN | WASF2 | WASF2, WAVE2: Wiskott-Aldrich syndrome protein family member 2 | 11.20 | Evidence | |||||
LYN | STAT6 | STAT6: Signal transducer and activator of transcription 6 | 11.10 | Evidence | |||||
LYN | ADRB2 | ADRB2, ADRB2R, B2AR: Beta-2 adrenergic receptor | 10.00 | Evidence | |||||
LYN | DAB2 | DAB2, DOC2: Disabled homolog 2 | 10.00 | Evidence | |||||
LYN | ACTN1 | ACTN1: Alpha-actinin-1 | 10.00 | Evidence | |||||
LYN | CAMK1 | CAMK1: Calcium/calmodulin-dependent protein kinase type 1 | 10.00 | Evidence | |||||
LYN | LAT | LAT: Linker for activation of T-cells family member 1 | 9.92 | Evidence | |||||
LYN | IL4R | IL4R, 582J2.1, IL4RA: Interleukin-4 receptor alpha chain precursor | 9.92 | Evidence | |||||
LYN | CCR2 | CCR2, CMKBR2: C-C chemokine receptor type 2 | 9.92 | Evidence | |||||
LYN | IL6ST | IL6ST: Interleukin-6 receptor subunit beta precursor | 9.92 | Evidence | |||||
LYN | PTPRC | PTPRC, RP11-553K8.4-001, hCG_1811178: Protein tyrosine phosphatase, receptor typ | 9.92 | Evidence |
![]() |
||||
LYN | CD247 | CD247, CD3Z, T3Z, TCRZ: T-cell surface glycoprotein CD3 zeta chain precursor | 9.92 | Evidence | |||||
LYN | CD79B | CD79B, B29, IGB: B-cell antigen receptor complex-associated protein beta-chain p | 9.92 | Evidence |
![]() |
||||
LYN | FCGR2B | FCGR2B, CD32, FCG2, IGFR2: Low affinity immunoglobulin gamma Fc region receptor | 9.92 | Evidence |
![]() |
||||
LYN | IRS1 | IRS1: Insulin receptor substrate 1 | 9.89 | Evidence | |||||
LYN | CFL1 | CFL1, CFL: Cofilin-1 | 9.88 | Evidence | |||||
LYN | IFNGR2 | IFNGT1, IFNGR2: Interferon-gamma receptor beta chain precursor | 9.84 | Evidence | |||||
LYN | IL12RB2 | IL12RB2: Interleukin-12 receptor beta-2 chain precursor | 9.14 | Evidence | |||||
LYN | ICOSLG | ICOSLG, B7H2, B7RP1, ICOSL, KIAA0653: ICOS ligand precursor | 9.14 | Evidence | |||||
LYN | PRKD1 | PRKD1, PKD, PKD1, PRKCM: Serine/threonine-protein kinase D1 | 9.0 | Evidence | |||||
LYN | PAK7 | PAK7, KIAA1264, PAK5: Serine/threonine-protein kinase PAK 7 | 9.0 | Evidence | |||||
LYN | STMN2 | STMN2, SCG10, SCGN10: Stathmin-2 | 8.92 | Evidence | |||||
LYN | HPCA | HPCA, BDR2: Neuron-specific calcium-binding protein hippocalcin | 8.92 | Evidence | |||||
LYN | PLEKHA5 | PLEKHA5, KIAA1686, PEPP2: Pleckstrin homology domain-containing family A member | 8.92 | Evidence | |||||
LYN | TRPM7 | TRPM7, CHAK1, LTRPC7: Transient receptor potential cation channel subfamily M me | 8.89 | Evidence | |||||
LYN | PKMYT1 | PKMYT1, MYT1: Membrane-associated tyrosine- and threonine-specific cdc2-inhibito | 8.86 | Evidence | |||||
LYN | ADAM8 | ADAM8, MS2: ADAM 8 precursor | 8.81 | Evidence | |||||
LYN | EPOR | EPOR: Erythropoietin receptor precursor | 8.55 | Evidence |
![]() |
||||
LYN | RPS6KA3 | RPS6KA3, ISPK1, RSK2: Ribosomal protein S6 kinase alpha-3 | 8.53 | Evidence | |||||
LYN | TGFBR2 | TGFBR2: TGF-beta receptor type-2 precursor | 8.19 | Evidence | |||||
LYN | PRKCA | PRKCA, PKCA, PRKACA: Protein kinase C alpha type | 7.99 | Evidence | |||||
LYN | MYL9 | MYL9, MLC2, MRLC1, MYRL2: Myosin regulatory light chain 2, smooth muscle isoform | 7.99 | Evidence | |||||
LYN | CTTN | CTTN, EMS1: Src substrate cortactin | 7.97 | Evidence | |||||
LYN | USP10 | USP10, KIAA0190: Ubiquitin carboxyl-terminal hydrolase 10 | 7.93 | Evidence | |||||
LYN | EEF1A1 | EEF1A1: Elongation factor 1-alpha | 7.52 | Evidence | |||||
LYN | CD3E | CD3E, T3E: T-cell surface glycoprotein CD3 epsilon chain precursor | 7.40 | Evidence | |||||
LYN | GHR | GHR: Growth hormone receptor precursor | 7.40 | Evidence | |||||
LYN | GSN | GSN: Gelsolin precursor | 7.26 | Evidence | |||||
LYN | ITGB1BP1 | ITGB1BP1, ICAP1: Integrin beta-1-binding protein 1 | 7.24 | Evidence | |||||
LYN | AGTPBP1 | AGTPBP1, RP11-30C23.1-005, hCG_1743691: AGTPBP1 protein | 7.10 | Evidence | |||||
LYN | HNRPK | N/A | 7.10 | Evidence |
![]() |
||||
LYN | PPP2R5A | PPP2R5A: Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha | 7.10 | Evidence | |||||
LYN | DUSP3 | DUSP3, VHR: Dual specificity protein phosphatase 3 | 6.52 | Evidence | |||||
LYN | MPL | MPL, TPOR: Thrombopoietin receptor precursor | 6.52 | Evidence | |||||
LYN | IL1RL1 | IL1RL1, DER4, ST2, T1: Interleukin-1 receptor-like 1 precursor | 6.52 | Evidence | |||||
LYN | CFL2 | CFL2: Cofilin-2 | 6.50 | Evidence | |||||
LYN | DNM2 | N/A | 6.40 | Evidence | |||||
LYN | PPID | PPID, CYP40, CYPD: 40 kDa peptidyl-prolyl cis-trans isomerase | 6.40 | Evidence | |||||
LYN | VAV2 | VAV2, RP11-153P4.1-003: Vav 2 oncogene | 6.40 | Evidence | |||||
LYN | SIPA1L1 | SIPA1L1, E6TP1, KIAA0440: Signal-induced proliferation-associated 1-like protein | 6.27 | Evidence | |||||
LYN | BCAR1 | BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 | 6.14 | Evidence |
![]() |
||||
LYN | S100A8 | S100A8, CAGA, CFAG, MRP8: Protein S100-A8 | 6.11 | Evidence | |||||
LYN | ZFP36 | ZFP36, G0S24, RNF162A, TIS11A, TTP: Tristetraproline | 6.01 | Evidence | |||||
LYN | IFNAR2 | N/A | 5.95 | Evidence | |||||
LYN | HLA-DQA1 | HLA-DQA1: HLA class II histocompatibility antigen, DQ(5) alpha chain precursor | 5.95 | Evidence | |||||
LYN | IL13RA1 | IL13RA1, IL13R, IL13RA: Interleukin-13 receptor alpha-1 chain precursor | 5.95 | Evidence | |||||
LYN | CD1A | CD1A: T-cell surface glycoprotein CD1a precursor | 5.88 | Evidence | |||||
LYN | PRLR | PRLR: Prolactin receptor precursor | 5.88 | Evidence | |||||
LYN | MIP | MIP, AQP0: Lens fiber major intrinsic protein | 5.88 | Evidence | |||||
LYN | CNTN2 | CNTN2, AXT, TAG1, TAX1: Contactin-2 precursor | 5.88 | Evidence | |||||
LYN | PPIA | PPIA, CYPA: Peptidyl-prolyl cis-trans isomerase A | 5.74 | Evidence | |||||
LYN | NPR1 | NPR1, ANPRA: Atrial natriuretic peptide receptor A precursor | 5.27 | Evidence | |||||
LYN | CSK | CSK: Tyrosine-protein kinase CSK | 5.22 | Evidence |
![]() |
||||
LYN | FCGR1A | FCGR1A, FCG1, FCGR1, IGFR1: High affinity immunoglobulin gamma Fc receptor I pre | 4.80 | Evidence | |||||
LYN | SLC9A3R1 | SLC9A3R1, NHERF: Ezrin-radixin-moesin-binding phosphoprotein 50 | 4.73 | Evidence | |||||
LYN | KIRREL | KIRREL, KIRREL1, NEPH1: Kin of IRRE-like protein 1 precursor | 4.68 | Evidence | |||||
LYN | DNM1 | DNM1, DNM: Dynamin-1 | 4.68 | Evidence | |||||
LYN | STYXL1 | STYXL1, DUSP24, MKSTYX: Serine/threonine/tyrosine-interacting-like protein 1 | 4.51 | Evidence | |||||
LYN | PLAUR | PLAUR, MO3, UPAR: Urokinase plasminogen activator surface receptor precursor | 4.48 | Evidence |
![]() |
||||
LYN | CAP1 | CAP1, CAP: Adenylyl cyclase-associated protein 1 | 4.36 | Evidence | |||||
LYN | MYD88 | 4.29 | Evidence | ||||||
LYN | RPA2 | RPA2, REPA2, RPA32, RPA34: Replication protein A 32 kDa subunit | 4.23 | Evidence | |||||
LYN | GNB2L1 | Lung cancer oncogene 7 | 4.06 | Evidence | |||||
LYN | FCGR2A | FCGR2A: Fc of IgG, low affinity IIa, receptor | 4.06 | Evidence |
![]() |
||||
LYN | JUN | JUN: Transcription factor AP-1 | 3.85 | Evidence | |||||
LYN | DSTN | DSTN, ACTDP, DSN: Destrin | 3.85 | Evidence | |||||
LYN | CCNH | CCNH: Cyclin-H | 3.76 | Evidence | |||||
LYN | RPS6KA6 | RPS6KA6, RSK4: Ribosomal protein S6 kinase alpha-6 | 3.74 | Evidence | |||||
LYN | IGFBP7 | IGFBP7, MAC25, PSF: Insulin-like growth factor-binding protein 7 precursor | 3.71 | Evidence | |||||
LYN | CAMK2G | Calcium/calmodulin-dependent protein kinase isoform A (Fragment) | 3.69 | Evidence | |||||
LYN | BRD2 | BRD2, KIAA9001, RING3: Bromodomain-containing protein 2 | 3.64 | Evidence | |||||
LYN | GNB1 | GNB1: Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | 3.64 | Evidence | |||||
LYN | SMAD2 | SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 | 3.64 | Evidence | |||||
LYN | DDX3X | DDX3X, DBX, DDX3: ATP-dependent RNA helicase DDX3X | 3.64 | Evidence | |||||
LYN | BTN3A3 | BTN3A3, BTF3: Butyrophilin subfamily 3 member A3 precursor | 3.54 | Evidence | |||||
LYN | SDF4 | SDF4, CAB45, PSEC0034: 45 kDa calcium-binding protein precursor | 3.54 | Evidence | |||||
LYN | VCP | VCP: Transitional endoplasmic reticulum ATPase | 3.47 | Evidence | |||||
LYN | CKAP1 | TBCB, CG22, CKAP1: Tubulin folding cofactor B | 3.47 | Evidence | |||||
LYN | TNNC2 | TNNC2: Troponin C, skeletal muscle | 3.34 | Evidence | |||||
LYN | SAFB | SAFB, HAP, HET, SAFB1: Scaffold attachment factor B | 3.28 | Evidence | |||||
LYN | VIL1 | VIL1, VIL: Villin-1 | 3.13 | Evidence | |||||
LYN | GJA1 | GJA1, GJAL: Gap junction alpha-1 protein | 3.12 | Evidence | |||||
LYN | CTLA4 | CTLA4, CD152: Cytotoxic T-lymphocyte protein 4 precursor | 3.12 | Evidence |
![]() |
||||
LYN | MAL2 | MAL2: Protein MAL2 | 3.07 | Evidence | |||||
LYN | EIF4EBP1 | EIF4EBP1: Eukaryotic translation initiation factor 4E-binding protein 1 | 3.03 | Evidence | |||||
LYN | PVALB | PVALB: Parvalbumin alpha | 3.01 | Evidence | |||||
LYN | IL3RA | IL3RA, IL3R: Interleukin-3 receptor alpha chain precursor | 2.90 | Evidence | |||||
LYN | KLF13 | KLF13, BTEB3, NSLP1: Krueppel-like factor 13 | 2.84 | Evidence | |||||
LYN | RAC2 | RAC2: Ras-related C3 botulinum toxin substrate 2 precursor | 2.69 | Evidence | |||||
LYN | AGTR1 | AGTR1, AGTR1A, AGTR1B, AT2R1, AT2R1B: Type-1 angiotensin II receptor | 2.65 | Evidence | |||||
LYN | LYPD3 | LYPD3, C4.4A, UNQ491/PRO1007: Ly6/PLAUR domain-containing protein 3 precursor | 2.65 | Evidence | |||||
LYN | TSHR | N/A | 2.63 | Evidence | |||||
LYN | PTPN11 | N/A | 2.63 | Evidence | |||||
LYN | CCT6A | CCT6A, CCT6, CCTZ: T-complex protein 1 subunit zeta | 2.63 | Evidence | |||||
LYN | BLNK | N/A | 2.62 | Evidence | |||||
LYN | UACA | UACA, KIAA1561: Uveal autoantigen with coiled-coil domains and ankyrin repeats | 2.54 | Evidence | |||||
LYN | BCR | N/A | 2.54 | Evidence | |||||
LYN | STAP2 | Uncharacterized protein ENSP00000317912 | 2.54 | Evidence | |||||
LYN | SIVA | SIVA1, SIVA: Apoptosis regulatory protein Siva | 2.54 | Evidence | |||||
LYN | MYO18A | 2.54 | Evidence | ||||||
LYN | PDZD2 | CDNA FLJ46853 fis, clone UTERU3009775, moderately similar to Rattus norvegicus P | 2.54 | Evidence | |||||
LYN | CAV1 | CAV1, CAV: Caveolin-1 | 2.48 | Evidence | |||||
LYN | CDC25B | CDC25B, CDC25HU2: M-phase inducer phosphatase 2 | 2.43 | Evidence | |||||
LYN | DUSP10 | DUSP10, MKP5: Dual specificity protein phosphatase 10 | 2.43 | Evidence | |||||
LYN | DOK6 | DOK6: Uncharacterized protein DOK6 | 2.43 | Evidence | |||||
LYN | PLEKHA4 | PLEKHA4, PEPP1: Pleckstrin homology domain-containing family A member 4 | 2.43 | Evidence | |||||
LYN | ANKK1 | ANKK1, PKK2, SGK288: Ankyrin repeat and protein kinase domain-containing protein | 2.43 | Evidence | |||||
LYN | TLR4 | TLR4: Toll-like receptor 4 precursor | 2.42 | Evidence | |||||
LYN | KIAA0853 | N/A | 2.42 | Evidence | |||||
LYN | RFXDC2 | RFXDC2: Regulatory factor X domain-containing protein 2. | 2.42 | Evidence | |||||
LYN | CD19 | N/A | 2.42 | Evidence |
![]() |
||||
LYN | HES1 | HES1, HL, HRY: Transcription factor HES-1 | 2.37 | Evidence | |||||
LYN | NIPBL | N/A | 2.28 | Evidence | |||||
LYN | DBNL | N/A | 2.28 | Evidence | |||||
LYN | MAP2K3 | N/A | 2.28 | Evidence | |||||
LYN | LMO6 | LMO6: LIM domain only protein 6 | 2.28 | Evidence | |||||
LYN | HSPA8 | HSPA8, HSC70, HSP73, HSPA10: Heat shock cognate 71 kDa protein | 2.28 | Evidence | |||||
LYN | LRRFIP1 | N/A | 2.28 | Evidence | |||||
LYN | ANP32B | ANP32B, APRIL, PHAPI2: Acidic leucine-rich nuclear phosphoprotein 32 family memb | 2.17 | Evidence | |||||
LYN | NOC2L | NOC2L: Nucleolar complex protein 2 homolog | 2.10 | Evidence | |||||
LYN | HSPD1 | 2.10 | Evidence | ||||||
LYN | PSMA7 | PSMA7: Proteasome subunit alpha type-7 | 2.08 | Evidence | |||||
LYN | PRMT5 | PRMT5, HRMT1L5, IBP72, JBP1, SKB1: Protein arginine N-methyltransferase 5 | 2.06 | Evidence | |||||
LYN | ACTG1 | ACTR2, ARP2: Actin-related protein 2 | 2.03 | Evidence | |||||
LYN | GNA15 | GNA15, GNA16: Guanine nucleotide-binding protein alpha-15 subunit | 1.98 | Evidence | |||||
LYN | KIAA0274 | N/A | 1.79 | Evidence | |||||
LYN | HSF1 | HSF1, HSTF1: Heat shock factor protein 1 | 1.76 | Evidence | |||||
LYN | PSEN1 | PSEN1, AD3, PS1, PSNL1: Presenilin-1 | 1.53 | Evidence | |||||
LYN | YEATS2 | KIAA1197, YEATS2: YEATS domain-containing protein 2 | 1.50 | Evidence | |||||
LYN | GMIP | GMIP: GEM-interacting protein | 1.41 | Evidence | |||||
LYN | IQGAP1 | IQGAP1, KIAA0051: Ras GTPase-activating-like protein IQGAP1 | 1.41 | Evidence | |||||
LYN | PSCD4 | PSCD4, CYT4: Cytohesin-4 | 1.41 | Evidence | |||||
LYN | DOCK2 | DOCK2, KIAA0209: Dedicator of cytokinesis protein 2 | 1.41 | Evidence | |||||
LYN | GNA12 | GNA12: Guanine nucleotide-binding protein alpha-12 subunit | 1.34 | Evidence | |||||
LYN | MCM3 | MCM3: DNA replication licensing factor MCM3 | 1.34 | Evidence | |||||
LYN | ASGR1 | ASGR1: Asialoglycoprotein receptor 1 | 1.34 | Evidence | |||||
LYN | POLR2A | POLR2A: Uncharacterized protein POLR2A | 1.34 | Evidence | |||||
LYN | NR4A2 | NR4A2, NOT, NURR1, TINUR: Orphan nuclear receptor NR4A2 | 1.34 | Evidence | |||||
LYN | SH2D2A | SH2D2A, SCAP, TSAD, VRAP: SH2 domain-containing protein 2A | 1.30 | Evidence | |||||
LYN | PTAFR | PTAFR, PAFR: Platelet-activating factor receptor | 1.30 | Evidence | |||||
LYN | ECT2 | ECT2: Protein ECT2 | 1.27 | Evidence | |||||
LYN | GP9 | GP9: Platelet glycoprotein IX precursor | 1.20 | Evidence | |||||
LYN | RNF20 | 1.16 | Evidence | ||||||
LYN | BUB3 | BUB3: Mitotic checkpoint protein BUB3 | 1.16 | Evidence | |||||
LYN | ABL2 | ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 | 1.13 | Evidence | |||||
LYN | SLA2 | SLA2, C20orf156, SLAP2: Src-like-adapter 2 | 1.13 | Evidence | |||||
LYN | MATK | MATK, CTK, HYL: Megakaryocyte-associated tyrosine-protein kinase | 1.13 | Evidence | |||||
LYN | LNK | SH2B3, LNK: SH2B adapter protein 3 | 1.13 | Evidence | |||||
LYN | RIN3 | N/A | 1.05 | Evidence | |||||
LYN | TESK1 | TESK1: Dual specificity testis-specific protein kinase 1 | 1.04 | Evidence | |||||
LYN | HLA-DMB | HLA-DMB, DMB, RING7: HLA class II histocompatibility antigen, DM beta chain prec | 1.03 | Evidence | |||||
LYN | ICAM3 | ICAM3: Intercellular adhesion molecule 3 precursor | 1.03 | Evidence | |||||
LYN | HLA-C | HLA-C, HLAC: HLA class I histocompatibility antigen, Cw-7 alpha chain precursor | 1.03 | Evidence | |||||
LYN | HLA-B | HLA-B, HLAB: HLA class I histocompatibility antigen, B-7 alpha chain precursor | 1.03 | Evidence | |||||
LYN | HLA-DMA | DMA, HLA-DMA, DAQB-96B10.1-001, DASS-67H14.8-001, XXbac-BCX136A3.1-001, XXbac-BP | 1.03 | Evidence | |||||
LYN | LILRB1 | N/A | 1.03 | Evidence |